Cargando…

Alzheimer’s Disease Drug Development Pipeline 2020

Detalles Bibliográficos
Autor principal:	Sabbagh, M.N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437724/ https://www.ncbi.nlm.nih.gov/pubmed/32236392 http://dx.doi.org/10.14283/jpad.2020.12

Ejemplares similares

Alzheimer's disease drug development pipeline: 2020
por: Cummings, Jeffrey, et al.
Publicado: (2020)

Alzheimer's disease drug development pipeline: 2019
por: Cummings, Jeffrey, et al.
Publicado: (2019)

Alzheimer's disease drug development pipeline: 2018
por: Cummings, Jeffrey, et al.
Publicado: (2018)

Alzheimer's disease drug development pipeline: 2017
por: Cummings, Jeffrey, et al.
Publicado: (2017)

Alzheimer's disease drug development pipeline: 2022
por: Cummings, Jeffrey, et al.
Publicado: (2022)

Alzheimer's disease drug development pipeline: 2021
por: Cummings, Jeffrey, et al.
Publicado: (2021)

Alzheimer's disease drug development pipeline: 2023
por: Cummings, Jeffrey, et al.
Publicado: (2023)

Alzheimer's drug-development pipeline: 2016
por: Cummings, Jeffrey, et al.
Publicado: (2016)

Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2020)

Erratum: Alzheimer's disease drug development pipeline: 2023
Publicado: (2023)

Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2023)

Alzheimer’s disease drug-development pipeline: few candidates, frequent failures
por: Cummings, Jeffrey L, et al.
Publicado: (2014)

Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2020
por: McFarthing, Kevin, et al.
Publicado: (2020)

2020–2021 Drug Updates: Investigational Therapeutics in the Pipeline
por: Moore, Donald C.
Publicado: (2022)

The development of an automated machine learning pipeline for the detection of Alzheimer’s Disease
por: Chedid, Nicholas, et al.
Publicado: (2022)

FDA position statement “Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry”
por: Sabbagh, Marwan N., et al.
Publicado: (2019)

Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer’s Disease
por: Arab, L, et al.
Publicado: (2011)

Refreshing the biologic pipeline 2020
por: Hodgson, John
Publicado: (2021)

Network Proximity-based computational pipeline identifies drug candidates for different pathological stages of Alzheimer's disease
por: Wu, Qihui, et al.
Publicado: (2023)

Advances in the Cystic Fibrosis Drug Development Pipeline
por: Esposito, Christine, et al.
Publicado: (2023)

Huntington’s Disease Drug Development: A Phase 3 Pipeline Analysis
por: Van de Roovaart, Hannah J., et al.
Publicado: (2023)

On the horizon—the value and promise of the global pipeline of Alzheimer's disease therapeutics
por: Cole, Michael A., et al.
Publicado: (2020)

A Functional Pipeline of Genome-Wide Association Data Leads to Midostaurin as a Repurposed Drug for Alzheimer’s Disease
por: Esteban-Martos, Alvaro, et al.
Publicado: (2023)

Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline
por: Tang, Ziqi, et al.
Publicado: (2019)

Antiepileptic drugs in development pipeline: A recent update
por: Kaur, Harjeet, et al.
Publicado: (2016)

Pipelines 2020: utility engineering, surveying, and multidisciplinary topics
por: Pulido, J Felipe, et al.
Publicado: (2020)

Antibiotics in the pipeline: a literature review (2017–2020)
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2021)

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
por: Sabbagh, Marwan N., et al.
Publicado: (2019)

What’s in the pipeline? Drugs in development for autism spectrum disorder
por: Sung, Min, et al.
Publicado: (2014)

Converging multi-modality datasets to build efficient drug repositioning pipelines against Alzheimer’s disease and related dementias
por: Yin, Zheng, et al.
Publicado: (2022)

Clinical trials of new drugs for Alzheimer disease: a 2020–2023 update
por: Huang, Li-Kai, et al.
Publicado: (2023)

Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020
por: Prasad, Neha K., et al.
Publicado: (2022)

Pipelines 2020: condition assessment, construction, rehabilitation, and trenchless technologies
por: Pulido, J Felipe, et al.
Publicado: (2020)

Benzimidazole-Based Schiff Base Hybrid Scaffolds: A Promising Approach to Develop Multi-Target Drugs for Alzheimer’s Disease
por: Hussain, Rafaqat, et al.
Publicado: (2023)

New Acetylcholinesterase Inhibitors for Alzheimer's Disease
por: Mehta, Mona, et al.
Publicado: (2012)

Advances in Alzheimer’s Disease Drug Development
por: Rafii, Michael S, et al.
Publicado: (2015)

The Alzheimer’s disease drug development landscape
por: van Bokhoven, Pieter, et al.
Publicado: (2021)

New Drugs for Neglected Diseases: From Pipeline to Patients
por: Pécoul, Bernard
Publicado: (2004)

A novel cascade machine learning pipeline for Alzheimer’s disease identification and prediction
por: Zhou, Kun, et al.
Publicado: (2023)

Clostridium difficile Drug Pipeline: Challenges in Discovery and Development of New Agents
por: Jarrad, Angie M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_03rki6qgraopc0kqi37hmkpa53